Apollo Hospitals Enterprise DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.77×	0.77×	0.75×	0.69×	0.74×
	0.91×	0.90×	0.89×	0.80×	0.80×
	11.8%	11.5%	10.4%	8.9%	8.6%
	1.18×	1.18×	1.17×	1.22×	1.20×
	2.23×	2.23×	2.39×	2.29×	2.21×
	21.6%	20.8%	19.3%	13.7%	13.5%
	22.0%	22.0%	19.1%	13.7%	13.9%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

APOLLOHOSP₹8,200.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health

₹ CrorePeersFORTIS MAXHEALTH MEDANTA SUNPHARMA CIPLA DRREDDY DIVISLAB TORNTPHARMMcap ₹1.18L Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.74	0.69	0.75	0.77	0.77
Interest Burden (Pretax/EBIT) ×	0.80	0.80	0.89	0.90	0.91
EBIT Margin %	8.63	8.94	10.39	11.47	11.78
Asset Turnover ×	1.20	1.22	1.17	1.18	1.18
Financial Leverage (Assets/Equity) ×	2.21	2.29	2.39	2.23	2.23
ROE (5-step product, year-end total equity) %	13.48	13.70	19.29	20.85	21.58
ROE (owners' profit / average owners' equity) %	13.86	13.69	19.09	21.95	21.95

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 145%.